NGL FINE CHEM LIMITED Intrinsic Value
NGLFINE · Healthcare · Current price ₹2,684.3
Is NGL FINE CHEM LIMITED undervalued?
DocStoX estimates the fair value of NGL FINE CHEM LIMITED at ₹1,176 per share, versus the current market price of ₹2,684. That puts the stock about -56.2% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹528), Relative P/E (₹2,635), Graham floor (₹882). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹528 (bear) to ₹1,176 (base) to ₹2,635 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹2,684 versus an intrinsic value of ₹1,176, NGL FINE CHEM LIMITED currently offers -56.2% of negative margin (i.e. a premium).
More on NGL FINE CHEM LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.